5 hours Ago By ABMN Staff
Aaron Wealth Advisors LLC bought a new stake in The Clorox Company ( NYSE:CLX – Free Report ) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 1,487 shares of the company’s stock, valued at approximately $242,000. Other hedge funds and other institutional investors also recently modified their holdings of the company.
Mizuho Securities USA LLC lifted its position in Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter.
Ilex Capital Partners UK LLP raised its holdings in shares of Clorox by 512.7% during the third quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company’s stock valued at $88,315,000 after buying an additional 453,624 shares during the last quarter.
International Assets Investment Management LLC boosted its position in shares of Clorox by 424.9% during the third quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock worth $877,390,000 after buying an additional 435,971 shares during the period.
Boston Trust Walden Corp grew its holdings in Clorox by 5,442.5% in the 3rd quarter. Boston Trust Walden Corp now owns 273,908 shares of the company’s stock worth $44,622,000 after buying an additional 268,966 shares in the last quarter.
Finally, Assenagon Asset Management S.A. increased its position in Clorox by 302.
0% in the 4th quarter. Assenagon Asset Management S.A.
now owns 353,367 shares of the company’s stock valued at $57,390,000 after acquiring an additional 265,455 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.
Wall Street Analysts Forecast Growth Several research analysts have recently issued reports on CLX shares. JPMorgan Chase & Co. increased their price target on Clorox from $167.
00 to $171.00 and gave the stock a “neutral” rating in a research note on Thursday, January 16th. Wells Fargo & Company raised shares of Clorox from an “underweight” rating to an “equal weight” rating and raised their target price for the company from $155.
00 to $157.00 in a research note on Tuesday, January 7th. Barclays reduced their price target on shares of Clorox from $139.
00 to $130.00 and set an “underweight” rating for the company in a research note on Friday, January 17th. Evercore ISI lowered their price objective on shares of Clorox from $140.
00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. Finally, TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and upped their target price for the stock from $155.
00 to $170.00 in a research report on Wednesday, November 6th. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company’s stock.
Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $156.54. Clorox Trading Down 0.
2 % Shares of NYSE CLX opened at $160.03 on Wednesday. The company has a quick ratio of 0.
62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.
The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.
The company has a market cap of $19.81 billion, a price-to-earnings ratio of 55.76, a P/E/G ratio of 2.
95 and a beta of 0.42. The business has a fifty day simple moving average of $164.
16 and a 200-day simple moving average of $156.91. Clorox ( NYSE:CLX – Get Free Report ) last posted its quarterly earnings data on Wednesday, October 30th.
The company reported $1.86 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.
50. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.
64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.
08%. The business’s quarterly revenue was up 27.0% on a year-over-year basis.
During the same period in the prior year, the firm earned $0.49 earnings per share. Sell-side analysts predict that The Clorox Company will post 6.
87 EPS for the current year. Clorox Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.
22 per share. This represents a $4.88 annualized dividend and a yield of 3.
05%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is currently 170.
04%. Clorox Profile ( Free Report ) The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International.
The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. See Also Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter .
.
